Literature DB >> 7761723

[Evaluation of commercial kits used for Chagas disease diagnosis in blood banks in Chile. II. Routine application].

M Lorca1, R Child, A García, M Silva, L Martínez, G Jerez, I Toledo, D Mezzano.   

Abstract

Aiming to study the applicability and reproducibility of four commercial kits used for the serological detection of Chagas disease (Chagatest-Inst Invest Paraguay, Ortho Chagas, Abbott Chagas (ELISA tests) and Estabilgen Hemo Chagas (indirect hemagglutination test)), a comparative serological study was performed in 256 sera samples coming from a highly endemic area, 249 samples from a low endemic area, 180 reference sera and 2264 samples coming from three blood banks. Specificity of the kits was excellent and sensitivity ranged from 60 to 100%. The indirect hemagglutination test has the lower sensitivity. Some disagreements in the results were observed in the three blood banks, probably due to an unsatisfactory reactive management. We conclude that ELISA tests should be recommended for routine detection of Chagas disease and that for this purpose, a net of laboratories under the direction of a national reference center should exist. This center should assess new commercial products, train technicians and supervise the laboratories.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7761723

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  2 in total

Review 1.  Safety of the blood supply in Latin America.

Authors:  Gabriel A Schmunis; Jose R Cruz
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

Review 2.  ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis.

Authors:  Pedro E A A Brasil; Liane De Castro; Alejandro M Hasslocher-Moreno; Luiz H C Sangenis; José U Braga
Journal:  BMC Infect Dis       Date:  2010-11-25       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.